Alterity Therapeutics (ATHE) Loans - Adjustments (2012 - 2013)
Alterity Therapeutics' (ATHE) quarterly Loans - Adjustments came in at $37063.5 in Q4 2013, up 4.17% year-on-year from $35580.6 in Q4 2012, and up 11.93% quarter-over-quarter from $33113.4 in Q2 2013.
Alterity Therapeutics (ATHE) Loans - Adjustments (2012 - 2013) Analysis & Trends
Alterity Therapeutics' Loans - Adjustments history runs 2 years deep, the most recent figure standing at $37063.5 for Q4 2013.
- On a quarterly basis, Loans - Adjustments rose 4.17% year-over-year to $37063.5 in Q4 2013; TTM through Dec 2013 was $37063.5, a 4.17% increase from a year earlier, with the FY2013 full-year figure at $34240.0, down 34.74% from the prior year.
- Loans - Adjustments advanced to $37063.5 in Q4 2013 per ATHE's latest filing, from $33113.4 in the prior quarter.
- Across five years, Loans - Adjustments topped out at $51366.4 in Q2 2012 and bottomed at $33113.4 in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 37,063.54 |
| Jun 30, 2013 | 33,113.35 |
| Dec 31, 2012 | 35,580.59 |
| Jun 30, 2012 | 51,366.44 |